Fine Needle Aspiration Cytology of Thyroid Nodules: Evaluation Using the Bethesda System with Emphasis on Indeterminate Categories

Read full text Summarise with VIRAT
Authors: Ratnesh Kumar, Rashmi Singh, Manish Kumar
Cited by: 0
References: 5

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Fine needle aspiration cytology (FNAC) is the primary diagnostic tool for the evaluation of thyroid nodules. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) provides standardized diagnostic categories with implied risk of malignancy and management guidelines. Indeterminate categories remain a diagnostic challenge due to variable malignancy risk. Objectives: To evaluate thyroid FNAC findings using the Bethesda system with special emphasis on indeterminate categories over a one-year period. Methods: A prospective descriptive study was conducted over one year, including 130 patients presenting with thyroid nodules. FNAC was performed and smears were categorized according to TBSRTC. Demographic data, cytological diagnosis, and distribution of indeterminate categories were analyzed using descriptive statistics. Results: Of the 130 thyroid FNAC cases, Bethesda Category II (Benign) was the most common (60.0%). Indeterminate categories (Bethesda III and IV) constituted 18.5% of cases. Bethesda III (AUS/FLUS) accounted for 10.0% and Bethesda IV (Follicular neoplasm/SFN) for 8.5%. Suspicious for malignancy (Bethesda V) and malignant lesions (Bethesda VI) together comprised 11.5% of cases. Conclusion: FNAC using the Bethesda system is an effective diagnostic approach for thyroid nodules. Indeterminate categories form a significant subset and require careful interpretation and appropriate clinical correlation to guide management.

Fields of Study & Subjects

Thyroid Cancer Diagnosis and Treatment Thyroid and Parathyroid Surgery Thyroid Disorders and Treatments

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
01
Publication date
30 January 2026
Language
EN